Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Operating Income 2009–2025
Cytokinetics, Incorporated annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cytokinetics, Incorporated operating income for the quarter ending March 31, 2026 was -183.6 M, a 17.98% increase year-over-year.
- Cytokinetics, Incorporated operating income for the twelve months ending March 31, 2026 was -617.5 M, a 18.87% increase year-over-year.
- Cytokinetics, Incorporated annual operating income for 2025 was -612.3 M, a 14.17% increase from 2024.
- Cytokinetics, Incorporated annual operating income for 2024 was -536.2 M, a 8.07% increase from 2023.
- Cytokinetics, Incorporated annual operating income for 2023 was -496.2 M, a 53.05% increase from 2022.
- Cytokinetics, Incorporated annual operating income for 2022 was -324.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytokinetics, Incorporated Operating Income — FAQ
Cytokinetics, Incorporated (CYTK) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytokinetics, Incorporated's operating income?
Cytokinetics, Incorporated (CYTK) reported operating income of -$612M for fiscal 2025.
Where can I see CYTK's operating income history?
The chart and table above show Cytokinetics, Incorporated's operating income by year and by quarter, including the growth rate.